Abstract
Nigeria has a maternal mortality rate (MMR) of 512 deaths per 100,000 live births, an estimate which indicates that maternal deaths are responsible for about a third of all deaths among women of reproductive age. The regional distribution of neonatal deaths in Nigeria showed that the North East region had the highest neonatal deaths. This study provides insight into identified factors and their influence on maternal and neonatal mortalities. Targeted policy implementation will emerge from the analysis of these factors with the aim of reducing the mortalities which will invariably contribute to the reduction of the global maternal and newborn mortality index
Multiple linear regression analyses using secondary time series data from the district health information system (DHIS2) for the period 2012-2021. Multivariable logistic regression analyses were also used to examine a series of predictor variables to determine those that best predict the outcome variables. Statistical significance for all regressions performed was determined at p□<□0.05.
Regression results showed a negative relationship between antenatal care and neonatal mortality implying that an increase in the number of women attending ANC will lead to a reduction in neonatal mortality by about 43%. The regression result showed a positive relationship between low birth weight and neonatal mortality implying that an increase in the number of live births with low birth weight will lead to an increase in neonatal mortality by 94%. Regression analysis on factors affecting maternal mortality showed that 4th antenatal care visits and above, health facility delivery, postnatal care within 3 days for mothers, and skilled birth attendance all have a negative relationship with maternal mortality. The regression results are all statistically significant (p<0.05).
The study revealed significant relationships between some factors (antenatal care, low birth weight, skilled birth attendants, health facility delivery, post-natal care for both mother and newborn) affecting maternal and neonatal mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This article did not receive any funding from any source
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical oversight was waived by the National Health Research Ethics committee of Nigeria (NHREC), please attached waiver letter in supplementary files.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data set used for the analysis have been submitted as a supporting information
